Bringing rapid genomic sequencing into routine infection management
19 May 2026
Infectious diseases are evolving rapidly, driven by emerging pathogens and rising antimicrobial resistance. In this video, clinical and industry leaders from Oxford Nanopore Technologies, Cepheid, and King’s College London explore how rapid genomic sequencing could transform the detection, management, and prevention of infections in the future.
As part of their expanded collaboration, Cepheid and Oxford Nanopore have worked together to develop a new research workflow that combines automated sample and library preparation with innovative nanopore-based sequencing. Experts representing the developers and one of the early research users of this integrated approach discuss how innovations such as lab‑in‑a‑cartridge technology and minimal hands‑on processes could support broader adoption and benefits beyond specialist laboratories.
For Research Use Only. Not for use in diagnostic procedures.
Interview recorded at ESCMID Global 2026.
About the company
Cepheid
Cepheid’s GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, Tuberculosis and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. Cepheid call this the PCRplus advantage.
Related products
Request Quote for All Products
GeneXpert System
CepheidCepheid's GeneXpert system family combines speed, accuracy, and simplicity to deliver PCR results anywhere testing is needed. The system automates sample preparation, PCR amplification, and detection using self-contained GeneXpert test cartridges.